High-altitude pulmonary hypertension now: A mechanism-informed, region-ready care framework
-
-
REFERENCES
[1] Humbert M., Kovacs G., Hoeper M. M., et al. (2022). 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 43:3618−3731. DOI:10.1093/eurheartj/ehac237 [2] Lichtblau M., Saxer S., Furian M., et al. (2020). Cardiac function and pulmonary hypertension in Central Asian highlanders at 3250 m. Eur Respir J 56:1902474. DOI:10.1183/13993003.02474-2019 [3] Yang X., Liu H. and Wu X. (2025). High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management. Clin Exp Med 25:79. DOI:10.1007/s10238-025-01577-3 [4] Batool Z., Amjad Kamal M. and Shen B. (2025). Advanced treatment strategies for high-altitude pulmonary hypertension employing natural medicines: A review. J Pharm Anal 15:101129. DOI:10.1016/j.jpha.2024.101129 [5] Luo Q. (2023). Chinese clinical pathway for diagnosis and treatment of pulmonary hypertension. Chinese Circulation Journal 38:691−703. DOI:10.3969/j.issn.1000-3614.2023.07.002 -
ABOUT THIS ARTICLE
Cite this article:
Wang J., Wang R., Li X., et al. (2026). High-altitude pulmonary hypertension now: A mechanism-informed, region-ready care framework. The Innovation Drug Discovery 1:100021. https://doi.org/10.59717/j.xinn-drugdisc.2026.100021
Welcome!
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.
Export File
Citation
Wang J., Wang R., Li X., et al. (2026). High-altitude pulmonary hypertension now: A mechanism-informed, region-ready care framework. The Innovation Drug Discovery 1:100021. https://doi.org/10.59717/j.xinn-drugdisc.2026.100021
Format
Content
DownLoad:
-
Figure 1.
Mechanism-informed and altitude-adapted framework for high-altitude pulmonary hypertension (HAPH)
